Literature DB >> 20357911

Identification of Pirh2D, an Additional Novel Isoform of Pirh2 Ubiquitin Ligase.

Jingxue Shi1, Ying Huang, M Saeed Sheikh.   

Abstract

Pirh2 is an E3 ubiquitin ligase that promotes tumor suppressor p53 ubiquitination and proteasomal degradation. Recently, we have reported the identification and characterization of two novel isoforms of Pirh2 named Pirh2B and Pirh2C and accordingly, reclassified the full-length Pirh2 as Pirh2A. Both Pirh2B and C negatively regulate p53 and also exhibit interactions with MDM2. Here, we report the existence of an additional Pirh2 isoform that we have named Pirh2D. Translation of nucleotide sequence predicts Pirh2D to be composed of 75 amino acids with a molecular mass of 8493.74 Da. Thus, Pirh2D is a truncated protein that harbors 67 amino-terminal amino acids identical to those in Pirh2A, Pirh2B and Pirh2C and has 8 additional unique amino acids at the carboxyl-terminal end. Further studies are needed to determine whether Pirh2D also functions in a manner similar to Pirh2B and Pirh2C.

Entities:  

Year:  2010        PMID: 20357911      PMCID: PMC2847410          DOI: 10.4255/mcpharmacol.10.04

Source DB:  PubMed          Journal:  Mol Cell Pharmacol        ISSN: 1938-1247


  10 in total

1.  Pirh2, a p53-induced ubiquitin-protein ligase, promotes p53 degradation.

Authors:  Roger P Leng; Yunping Lin; Weili Ma; Hong Wu; Benedicte Lemmers; Stephen Chung; John M Parant; Guillermina Lozano; Razqallah Hakem; Samuel Benchimol
Journal:  Cell       Date:  2003-03-21       Impact factor: 41.582

2.  The p53 paddy wagon: COP1, Pirh2 and MDM2 are found resisting apoptosis and growth arrest.

Authors:  Chad A Corcoran; Ying Huang; M Saeed Sheikh
Journal:  Cancer Biol Ther       Date:  2004-08-01       Impact factor: 4.742

Review 3.  The p53 orchestra: Mdm2 and Mdmx set the tone.

Authors:  Mark Wade; Yunyuan V Wang; Geoffrey M Wahl
Journal:  Trends Cell Biol       Date:  2010-02-19       Impact factor: 20.808

4.  Identification and characterization of two novel isoforms of Pirh2 ubiquitin ligase that negatively regulate p53 independent of RING finger domains.

Authors:  Chad A Corcoran; JoAnne Montalbano; Hong Sun; Qin He; Ying Huang; M Saeed Sheikh
Journal:  J Biol Chem       Date:  2009-05-29       Impact factor: 5.157

Review 5.  Blinded by the Light: The Growing Complexity of p53.

Authors:  Karen H Vousden; Carol Prives
Journal:  Cell       Date:  2009-05-01       Impact factor: 41.582

6.  Smac deficiency affects endoplasmic reticulum stress-induced apoptosis in human colon cancer cells.

Authors:  Qin He; Jingxue Shi; Samantha Jones; Jie An; Yuxin Liu; Ying Huang; M Saeed Sheikh
Journal:  Mol Cell Pharmacol       Date:  2009

7.  ARF-BP1/Mule is a critical mediator of the ARF tumor suppressor.

Authors:  Delin Chen; Ning Kon; Muyang Li; Wenzhu Zhang; Jun Qin; Wei Gu
Journal:  Cell       Date:  2005-07-01       Impact factor: 41.582

8.  Sulindac Sulfide Differentially Induces Apoptosis in Smac-Proficient and -Deficient Human Colon Cancer Cells.

Authors:  Jingxue Shi; Qin He; Jie An; Hong Sun; Ying Huang; M Saeed Sheikh
Journal:  Mol Cell Pharmacol       Date:  2009-01-01

9.  The ubiquitin ligase COP1 is a critical negative regulator of p53.

Authors:  David Dornan; Ingrid Wertz; Harumi Shimizu; David Arnott; Gretchen D Frantz; Patrick Dowd; Karen O'Rourke; Hartmut Koeppen; Vishva M Dixit
Journal:  Nature       Date:  2004-04-21       Impact factor: 49.962

Review 10.  Tumor suppressive functions of p53.

Authors:  Jack T Zilfou; Scott W Lowe
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-11       Impact factor: 10.005

  10 in total
  2 in total

Review 1.  Pirh2 RING-finger E3 ubiquitin ligase: its role in tumorigenesis and cancer therapy.

Authors:  Yong-Sam Jung; Yingjuan Qian; Xinbin Chen
Journal:  FEBS Lett       Date:  2012-04-03       Impact factor: 4.124

Review 2.  The Role of E3 Ligase Pirh2 in Disease.

Authors:  Alexandra Daks; Olga Fedorova; Sergey Parfenyev; Ivan Nevzorov; Oleg Shuvalov; Nickolai A Barlev
Journal:  Cells       Date:  2022-04-30       Impact factor: 7.666

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.